Key Points
- Liam Condon, a Johnson Matthey insider, bought 10 shares on Jan 13 at GBX 2,321 (total £232.10) and previously bought 14 shares on Dec 10 and 10 shares on Nov 12, showing repeated insider purchases.
- Johnson Matthey shares opened at GBX 2,362 (near a 12‑month high of GBX 2,382) with a market cap of £3.96bn and a negative PE (-35.84); analysts give a consensus rating of Moderate Buy and a consensus target of GBX 2,248.
Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon acquired 10 shares of the firm's stock in a transaction on Tuesday, January 13th. The shares were bought at an average cost of GBX 2,321 per share, with a total value of £232.10.
Liam Condon also recently made the following trade(s):
- On Wednesday, December 10th, Liam Condon bought 14 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 2,013 per share, for a total transaction of £281.82.
- On Wednesday, November 12th, Liam Condon bought 10 shares of Johnson Matthey stock. The stock was bought at an average cost of GBX 2,165 per share, for a total transaction of £216.50.
Johnson Matthey Price Performance
Johnson Matthey stock opened at GBX 2,362 on Thursday. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The business has a 50 day simple moving average of GBX 2,117.36 and a 200-day simple moving average of GBX 1,997.90. Johnson Matthey PLC has a 12 month low of GBX 1,131 and a 12 month high of GBX 2,382. The stock has a market capitalization of £3.96 billion, a PE ratio of -35.84, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its quarterly earnings data on Thursday, November 20th. The company reported GBX 51.20 earnings per share for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. Equities analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on JMAT shares. Deutsche Bank Aktiengesellschaft increased their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a "buy" rating in a report on Thursday, October 9th. Citigroup boosted their target price on Johnson Matthey from GBX 1,800 to GBX 2,100 and gave the stock a "neutral" rating in a research report on Tuesday, October 21st. Berenberg Bank cut their target price on Johnson Matthey from GBX 2,100 to GBX 2,050 and set a "hold" rating for the company in a research note on Tuesday, November 25th. Jefferies Financial Group raised their price target on Johnson Matthey from GBX 2,200 to GBX 2,420 and gave the company a "buy" rating in a report on Tuesday, October 14th. Finally, Panmure Gordon reaffirmed a "buy" rating and set a GBX 2,370 price objective on shares of Johnson Matthey in a report on Monday, November 24th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of GBX 2,248.
Get Our Latest Report on Johnson Matthey
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
